Cesca Therapeutics (KOOL) Misses Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts KOOL Hot Sheet
Price: $14.65 +0.69%
Financial Fact:
Research and development: 670K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Research and development: 670K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Cesca Therapeutics (NASDAQ: KOOL) reported Q2 EPS of ($0.11), $0.03 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $4.6 million versus the consensus estimate of $4.08 million.
For earnings history and earnings-related data on Cesca Therapeutics (KOOL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- RenovoRx regains Nasdaq minimum bid price compliance
- BofA maintains underperform ratings on six BDC stocks
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
